Is delta-8 THC legal? The 12 Nov hemp change and 21 states

Two federal laws set the dates. Public Law 119-37, which became law on 12 Nov 2025, rewrites the hemp definition in 7 U.S.C. 1639o effective 365 days after enactment, which is 12 Nov 2026 (Pub. L. 119-37, s. 781). Public Law 119-103, a stopgap spending law signed on 2 Sep 2026, says that until 11 Dec 2026 the rewrite reaches only intermediate and finished hemp-derived products holding a cannabinoid that Cannabis sativa L. is not capable of producing naturally (Pub. L. 119-103, s. 2019). The act does not say whether 11 Dec itself falls inside the limited period, so the full rewrite applies after 11 Dec 2026 on either reading, and possibly on that day. The same act funds the government until 11 Dec 2026 (Division A, s. 106). Another act of Congress would be needed to move either date.

Until 12 Nov 2026, hemp means the plant and anything from it, including extracts, cannabinoids and isomers, with no more than 0.3% delta-9 THC on a dry weight basis (7 U.S.C. 1639o(1)). The statute names delta-9 THC alone, not THCA or delta-8, and sets a share of weight rather than a milligram cap, though USDA's rules already count THCA in a grower's pre-harvest test (7 CFR 990.1). Hemp in that sense is excluded from the federal definition of marijuana (21 U.S.C. 802(16)(B)).

From 12 Nov to 11 Dec 2026, the only products that leave the definition are those containing a cannabinoid the plant cannot produce naturally, whether sold finished or as an intermediate such as a distillate (7 U.S.C. 1639o(1)(C)(ii)(I) and (iv)(I), as amended; Pub. L. 119-103, s. 2019). For every other product, including THCA flower and, on FDA's description of it as a natural cannabinoid, delta-8, the 2018 definition keeps applying through that window.

After 11 Dec 2026 the whole rewrite applies. Hemp then means the plant and its derivatives with no more than 0.3% total THC, counting THCA, by dry weight. It excludes intermediate products with cannabinoids the plant cannot make, with cannabinoids synthesized or manufactured outside the plant, or with more than 0.3% combined THC and similar cannabinoids; intermediate products sold to consumers as finished goods; and finished products with cannabinoids the plant cannot make, with cannabinoids made outside the plant, or with more than 0.4 mg per container of total THC, THCA included, plus any cannabinoid the Secretary of Health and Human Services finds similar to THC or that is marketed as similar (Pub. L. 119-37, s. 781). A container is the innermost package touching the product, such as a jar, bag, packet, can or cartridge.

The law also told FDA to publish, within 90 days of enactment, a list of cannabinoids the plant is known to produce naturally, a list of naturally occurring THC-class cannabinoids, a list of other cannabinoids treated as similar to THC, and more detail on what counts as a container (Pub. L. 119-37, s. 781(3)). No FDA notice publishing those lists had appeared in the Federal Register by 3 Nov 2026. Two points therefore remain unsettled: exactly which cannabinoids count as ones the plant cannot produce during the 12 Nov window, and which cannabinoids beyond THC and THCA count toward the 0.4 mg cap.

Delta-8 THC. FDA describes delta-8 as one of the cannabinoids the plant produces naturally, though not in significant amounts, and says concentrated delta-8 is typically manufactured from hemp-derived CBD. On that description delta-8 is not a cannabinoid the plant cannot produce, so the 12 Nov step does not reach it, while delta-8 converted from CBD is a cannabinoid the plant can produce but that was manufactured outside it, which is excluded from hemp after 11 Dec 2026 (Pub. L. 119-37, s. 781). Delta-8 is itself a tetrahydrocannabinol, so after 11 Dec it also counts toward the 0.4 mg container cap in the text. No agency has published a reading of either clause, which is why the treatment of delta-8 between 12 Nov and 11 Dec is unsettled.

THCA flower. Until 11 Dec 2026 the statute names delta-9 THC only (7 U.S.C. 1639o(1)), but USDA's hemp rules treat a grower's plants as marijuana, to be destroyed, when total THC counting THCA exceeds the limit (7 CFR 990.1, 990.27); neither text says how THCA counts in flower tested after harvest. USDA already requires licensed growers' pre-harvest tests to report total THC, the sum of THC and THCA after decarboxylation, and says high-THCA cannabis is not a defined term (USDA AMS FAQ). After 11 Dec the statute itself counts THCA toward the 0.3% plant limit, so flower above 0.3% total THC is not hemp (Pub. L. 119-37, s. 781). Whether packaged flower is also a final hemp-derived cannabinoid product subject to the 0.4 mg container cap is not spelled out; Missouri's new law names smokable flower with any THCA as a covered product (RSMo 195.900).

Delta-9 hemp gummies and drinks. Until 11 Dec 2026 a gummy or drink is hemp if its delta-9 THC is no more than 0.3% by dry weight, a percentage with no milligram ceiling, unless it holds a cannabinoid the plant cannot produce, which takes it out from 12 Nov. After 11 Dec the line is 0.4 mg of total THC in each can, bottle, bag or packet, and a finished product above it is not hemp however its THC was made (Pub. L. 119-37, s. 781). Executive Order 14370 of 18 Dec 2025 states that some full-spectrum CBD products will again be controlled as marijuana once section 781 applies, because their THC exceeds the per-container threshold.

THC-O, HHC and other synthesized cannabinoids. Products holding a cannabinoid the plant cannot produce leave hemp on 12 Nov 2026, and after 11 Dec any product with a cannabinoid synthesized or manufactured outside the plant does too, whether or not the plant can make it (Pub. L. 119-37, s. 781, and Pub. L. 119-103, s. 2019). Which compounds belong in the first group is what FDA's list was meant to settle. DEA's position does not wait for either date: its 2020 rule says all synthetically derived tetrahydrocannabinols remain Schedule I, and its rule of 4 May 2026 gave HHC its own Schedule I listing, describing it as a synthetic substance controlled as a tetrahydrocannabinol (85 FR 51639; 91 FR 23913).

DEA treats converted THC as synthetic. In its 4 May 2026 rule listing HHC, DEA wrote that only tetrahydrocannabinols in or derived from the cannabis plant, not synthetic ones, are excluded from control as THC in hemp, and that tetrahydrocannabinols produced through chemical conversion, even from hemp, are considered synthetically produced under the Controlled Substances Act (91 FR 23913). On that reading, delta-8 made from CBD is a Schedule I substance now, before either 2026 date. DEA's 2020 interim final rule said all synthetically derived tetrahydrocannabinols remain in Schedule I without addressing THC converted from hemp CBD (85 FR 51639), and a DEA letter of 15 Sep 2021, as quoted by the Ninth Circuit, described synthetic delta-8 as made from non-cannabis materials.

A federal appeals court read the 2018 text the other way. In AK Futures LLC v. Boyd Street Distro, a trademark case decided on 19 May 2022, the Ninth Circuit, affirming a preliminary injunction on the record before it, held that the plain and unambiguous text of the 2018 Farm Bill compelled the conclusion that the delta-8 THC products before it were lawful, and that the hemp definition does not turn on how a cannabinoid is manufactured (No. 21-56133). That ruling applied the pre-2026 definition, which counted delta-9 THC only, and came four years before DEA's HHC rule. The definition that applies after 11 Dec 2026 excludes cannabinoids manufactured outside the plant expressly.

FDA says it is illegal to sell in interstate commerce any food to which THC or CBD has been added, and that THC and CBD products cannot be sold as dietary supplements, because both are active ingredients in approved drugs (21 U.S.C. 331(ll) and 321(ff)(3)(B), as explained in FDA's Q&A). Its consumer page says delta-8 products have not been evaluated or approved by FDA. The 2025 law required FDA to publish its cannabinoid lists within 90 days; no FDA notice publishing them had appeared in the Federal Register by 3 Nov 2026.

USDA regulates growing, not retail products. Its hemp program requires licensed growers to have crops sampled within 30 days before harvest and tested for total THC, and its hemp page says it has delayed until 31 Dec 2026 enforcement of the rule that testing labs be registered with DEA (USDA AMS). Executive Order 14370 of 18 Dec 2025 directed White House staff to work with Congress on the definition of final hemp-derived cannabinoid products so that suitable full-spectrum CBD products stay available, and to develop guidance on THC limits per serving (s. 2(b)). The order is to be carried out consistent with applicable law (s. 3(b)), so section 781 stands as written unless Congress amends it.

No. The final rule effective 28 Apr 2026 moved two groups into Schedule III: marijuana-containing drug products that carry FDA approval, and marijuana covered by a state-issued license for medical manufacture, distribution or dispensing, along with an expedited DEA registration for those state medical licensees (FR 2026-08176, 91 FR 22714). It states that it does not apply to synthetically derived THC, which remains in Schedule I, and that it does not affect the status of hemp.

Everything outside those two groups stays where it was. Adult-use cannabis sold in state-licensed stores remains Schedule I under federal law; a separate proposal to move all marijuana to Schedule III was set for a DEA hearing from 29 Jun 2026, and no final rule on it had been published by 3 Nov 2026 (91 FR 22777), and the rule itself notes that the hemp definition is being amended from 12 Nov 2026, with a corresponding effect on the federal definition of marijuana (91 FR 22716). A hemp product that falls outside the new definition becomes marijuana, or synthetic THC where DEA treats its THC as synthetic, and stays out of Schedule III unless it is an FDA-approved drug product or marijuana held under a state medical license. Our flying guide and national parks guide explain what the rule means for carrying licensed cannabis.

Arizona and Washington keep intoxicating hemp THC inside licensed cannabis retail. Arizona's Attorney General concluded in Opinion I24-005, posted on 11 Mar 2024, that state law does not let anyone without a license from the Department of Health Services sell delta-8 or other hemp-synthesized intoxicants, because Arizona's hemp law excludes ingestible products other than food made from sterile hemp seed or seed oil (A.R.S. 3-311(5)). On 24 Mar 2025 the office warned retailers that THC edibles and drinks may not be sold without a marijuana establishment license, and asked police to hold off enforcing until 24 Apr 2025. Washington's Liquor and Cannabis Board says that under a 2023 law only licensed cannabis retailers may sell products with detectable THC, delta-8 included, and that the same products mailed in from out of state remain illegal (SB 5367).

Connecticut and Maryland draw milligram lines. Connecticut's Department of Consumer Protection treats a high-THC hemp product, one with more than 1 mg of total THC per serving or 5 mg per container, or more than 0.3% for flower, as cannabis that only licensed dispensaries and retailers may sell, and state law directs DCP to list synthetic cannabinoids, those made by a chemical conversion the department has not approved, in Schedule I (Conn. Gen. Stat. 21a-240, 21a-243(j)); a moderate-THC product, 0.5 mg to 5 mg per container, needs a DCP vendor registration (DCP). Since 1 Oct 2026, endorsed package stores can sell THC drinks holding up to 5 mg a container, and licensed cannabis stores drinks holding up to 10 mg, in both cases to buyers 21 or older (Public Act 26-8; DCP). Maryland bars anyone without a cannabis license from selling a product to eat or inhale with more than 0.5 mg of THC per serving or 2.5 mg per package, counts delta-8, delta-9 and delta-10 however they were made, sets 21 as the buying age for those products and bans selling cannabinoid products not derived from naturally occurring constituents; hemp tinctures with at least 15 parts CBD to 1 part THC, holding no more than 2.5 mg of THC a serving or 100 mg a package, are exempt from the caps (Alcoholic Beverages and Cannabis Article 36-1102).

Michigan, Ohio and Nevada fold intoxicating hemp into marijuana law. Michigan defines THC to include tetrahydrocannabinols whether artificially or naturally derived, and counts a consumer product over 0.3% THC, or over the regulator's total THC limit for consumables, as marihuana (MCL 333.27953). Ohio has used a federal-style definition since 20 Mar 2026: a finished product with cannabinoids made outside the plant, or a container holding over 0.4 mg of total THC, is not hemp (R.C. 928.01), which makes it marihuana under Ohio law. Nevada counts delta-8 as THC (NRS 453.139), treats a hemp product over the state's hemp THC limit as marijuana (NRS 453.096), bars anyone from producing, distributing or selling a synthetic cannabinoid, a term that takes in any cannabinoid not taken from the plant without a chemical reagent, such as delta-8 converted from CBD (NRS 453.572, 678A.239) and, under a 2025 law, makes unlicensed hemp sellers post a sign at each entrance saying the location is not licensed to sell cannabis (NRS 678A.660).

California treats any hemp product with a detectable amount of THC as intoxicating and restricts its sale. The Department of Cannabis Control lists as prohibited hemp products with synthetic cannabinoids, inhalable hemp products such as pre-rolls and vape cartridges, alcoholic drinks with hemp cannabinoids and products made outside the regulated market, and says that since 1 Jan 2026 state and local agencies may take illegal intoxicating hemp off shelves and fine the seller (AB 8, signed 2 Oct 2025). Until 1 Jan 2028, state law bars licensed cannabis businesses from selling industrial hemp (B&P 26000.5); from 1 Jan 2028 intoxicating hemp must be made, tested, taxed and sold like licensed cannabis.

Colorado's Marijuana Enforcement Division told licensees on 12 Apr 2024 that converting CBD into THC for regulated products is a license violation, that regulated businesses may not possess synthetically manufactured products or use them as ingredients, and that hemp products may not be sold in Colorado if they hold more than 1.75 mg of THC per serving or less than 15 parts CBD to 1 part THC, counting delta-8, delta-10 and THCA as THC; edibles that qualify may go only to buyers 21 and older unless they hold under 1.25 mg of THC and more than 20 parts CBD to 1 part THC (MED notice). Oregon lets hemp items be sold outside licensed stores only if they hold no more than 0.3% total THC, stay within the Commission's THC limits and contain no artificially derived cannabinoids, a term OLCC says covers delta-8 made from CBD; only buyers 21 or older may purchase items with 0.5 mg of THC or more (OLCC).

New Jersey rewrote its hemp law in 2026. Under P.L.2025, c.215, signed on 12 Jan 2026 and revised by P.L.2026, c.7, the sale of cannabinoids synthesized in a laboratory, even ones the plant also makes, is banned; since 13 Apr 2026 anything other than a drink holding above 0.4 mg of total THC in a container counts as cannabis that only Commission licensees may make and sell; and no product with any detectable THC may go to anyone under 21 (CRC). Hemp THC drinks may be sold by holders of plenary wholesale and plenary retail distribution liquor licenses and by licensed cannabis retailers until 13 Nov 2026, and the CRC says that from 14 Nov any hemp drink over 0.4 mg per container is cannabis sold only by licensed Class 5 retailers. New York's hemp rules bar synthetic, artificially derived and isomerized cannabinoids, naming delta-8 and delta-10, cap edible hemp products at 1 mg of total THC per serving and 10 mg per package, and bar sales to anyone under 21 of hemp products over 0.5 mg of THC per serving, concentrates or flower (9 NYCRR 114.8, 114.16).

Illinois's new Hemp Act changes what shops may sell from 12 Nov 2026. From that date, a final consumer hemp product sold in the state may not contain cannabinoids the plant cannot produce naturally or that were synthesized or made outside the plant, and its container may hold no more than 0.4 mg of total THC, THCA included; it also may not be meant for smoking or vaping, may not contain alcohol, tobacco or nicotine, and must be tested, child-resistant and prepackaged (Public Act 104-463, Illinois Hemp Act, s. 5, 35). Products from the plant that do not meet the Act's hemp definition are treated as cannabis under the Cannabis Regulation and Tax Act (s. 40), which only licensed businesses may sell.

Missouri folds hemp THC into its marijuana system the same day. House Bill 2641 makes hemp-derived cannabinoid products marijuana that only facilities licensed under Article XIV of the state constitution may make, test, transport or sell, makes a violation a class D felony carrying a fine of $5,000 for each transaction, and keeps the word 'dispensary', or any similar word, out of the name of a business selling CBD, hemp or cannabinoid products unless it is a licensed dispensary (RSMo 195.900).

Missouri's dates depend on the product. The law applies from 12 Nov 2026 to products with cannabinoids the plant cannot make or that were made outside the plant, smokable flower with any THCA, and solid edibles such as gummies, tablets and baked goods with hemp delta-9 above the levels found naturally in the source plant. Because Congress delayed the federal change, other products, such as drinks, are covered only while federal restrictions prohibit them, which on the federal schedule means after 11 Dec 2026, and in the meantime they may not be sold to anyone under 21 (RSMo 195.900(11)).

Texas has listed delta-8 as a Schedule I controlled substance since 31 Jul 2026. The Department of State Health Services says only trace amounts produced naturally by the hemp plant are allowed, that the Supreme Court of Texas confirmed in DSHS v. Sky Marketing Corp. that delta-8 is a controlled substance, and that it can hold products whose labels list delta-8, or whose tests show more than trace amounts of tetrahydrocannabinols such as delta-8, and pass them to law enforcement (DSHS). Hemp shops may still sell consumable hemp products with no more than 0.3% delta-9 THC, measured since 31 Mar 2026 as total delta-9 THC counting THCA, and every seller must check government ID and refuse buyers under 21 (25 TAC 300.101, 300.701).

Senate Bill 1257, in force since 1 Nov 2026, lists tetrahydrocannabinols in Oklahoma's Schedule I instead of Schedule III, with a definition that takes in THC from industrial hemp; it also tests hemp by delta-9 THC plus THCA, capped together at 0.3% once decarboxylated (63 O.S. 2-101, 2-204). Stores still need no license to sell industrial hemp products made from hemp grown legally in Oklahoma or another state (63 O.S. 1-1431(C)).

Minnesota licenses hemp THC sales outside dispensaries but leaves delta-8 out. A lower-potency hemp edible, sold by OCM-licensed hemp retailers that include liquor stores and bars, may hold no more than 5 mg of delta-9 THC per serving or 10 mg in a single-container drink, no more than 0.5 mg per serving of all other cannabinoids combined, and no artificially derived cannabinoid other than delta-9, a category the statute says includes any THC created from CBD (Minn. Stat. 342.01, subd. 6, 50). Retailers must check that every buyer is 21 or older (342.46, subd. 3). Artificially derived cannabinoids other than delta-9 may reach buyers only in hemp-derived consumer products sold under a cannabis business license, in product types the Office of Cannabis Management approves (342.01, subd. 37; 342.06; 342.09, subd. 4).

New Mexico's hemp rule, in force since 28 Jan 2026, bars hemp facilities, a term that covers extraction, manufacturing and warehouse sites and retail manufacturers that make or repackage what they sell, from making, offering or selling semi-synthetic cannabinoids, defined as one cannabinoid chemically converted into another, except for an approved list of nine that does not include delta-8 (20.10.2.7, 20.10.2.11 NMAC). Most finished hemp products may hold no more than 0.3% total THC, 2 mg of THC per serving and 20 mg per package, with THC measured as delta-9 after decarboxylation; tinctures, broad-spectrum products, cosmetics and vapes have their own limits or exemptions (20.10.2.12 NMAC).

Florida lets hemp extract products be sold outside its medical marijuana treatment centers if they meet its hemp statute: no more than 0.3% total delta-9 THC, no sale to anyone under 21 of products meant to be eaten or inhaled, and no controlled substances in the product; hemp-derived cannabinoids that comply are not controlled substances under state law (s. 581.217). The statute measures delta-9 THC and does not name delta-8, while Florida's drug schedule lists delta-8 tetrahydrocannabinols, natural or synthetic, among the synthetic cannabinoids in Schedule I, with no hemp exception written into that entry (s. 893.03(1)(c)190).

Pennsylvania's Department of Agriculture permits hemp growers and processors under the PA Hemp General Permit and lists 170 growing and 32 processing permits for 2026; its hemp page says nothing about THC limits for retail products or a buying age (PDA). Philadelphia acts on its own. From 12 Nov 2026, Bill No. 260163, passed 16 to 0 on 4 Jun 2026 and signed on 15 Sep 2026, makes it unlawful in the city to sell anything the federal hemp definition excludes, or to sell an intoxicating substance to a buyer under 21; once the city issues regulations, every shop location will also need a city permit.

Massachusetts's Cannabis Control Commission leaves hemp to the Department of Agricultural Resources. Its regulations define hemp as cannabis with no more than 0.3% delta-9 THC, or combined delta-9 THC and THCA, and exclude hemp from marijuana, while marijuana includes tetrahydrocannabinol as defined in chapter 94G, section 1 (935 CMR 500.002). The Commission's regulations do not mention delta-8. In all three states the federal definition, including the 11 Dec 2026 version, applies alongside state law.

Check the license, not the sign. Every licensed adult-use store appears on its regulator's public license list, and each state's rules page on this site links to that lookup. From 12 Nov 2026 Missouri bars any business that sells CBD, hemp or cannabinoid products, other than a licensed dispensary, from using 'dispensary' or a similar word in its name (RSMo 195.900). Nevada requires unlicensed hemp sellers to post a sign at each entrance saying the location is not licensed to sell cannabis, and another where sales are made saying all hemp products contain less than the legal limit of THC (NRS 678A.660). In New York, a hemp retailer has to display its OCM license for cannabinoid hemp in a conspicuous spot and keep cannabinoid products visibly separate from other hemp goods (9 NYCRR 114.11).

Look for the universal symbol. California's licensed cannabis packages must carry the state's universal symbol, printed in black or white against a contrasting background and no shorter than half an inch (4 CCR 17410), and our label guide shows the California and New York marks. The symbol is a cannabis label requirement, not a hemp one. Hemp labels have their own rules where a state writes them: from 12 Nov 2026 Illinois requires the milligrams of each cannabinoid present above 0.4 mg, per serving and per container, a batch number and a scannable link to the lab certificate, and bars labels that present the product as a cannabis product (Public Act 104-463, s. 35).

Read the THC line against the state's caps. A Minnesota hemp edible may hold no more than 5 mg of delta-9 THC per serving, a New York hemp edible 1 mg per serving, a Connecticut moderate-THC product 5 mg per container and a Maryland product sold without a cannabis license 0.5 mg per serving or 2.5 mg per package (Minn. Stat. 342.01, subd. 50; 9 NYCRR 114.8; DCP; Article 36-1102). A higher figure on a package in a shop with no cannabis license points to a product outside state law, and after 11 Dec 2026 a finished hemp product goes outside the federal definition once its container holds over 0.4 mg of total THC.

Federal law protects moving hemp, not products outside the definition. The 2018 Farm Bill bars states and tribes from prohibiting the transportation or shipment through their territory of hemp or hemp products produced under the federal hemp program (7 U.S.C. 1639o note; Pub. L. 115-334, s. 10114(b)). That protection reaches only what meets the federal definition, so after 11 Dec 2026 a bag of gummies holding over 0.4 mg of total THC, or delta-8 made from CBD, is not hemp in transit. Missouri's new law says it does not prohibit interstate commerce in hemp or shipping hemp through the state (RSMo 195.900).

State law applies at both ends of a trip. Washington's regulator says delta-8 and similar products shipped in from other states are still illegal there, and New Jersey bans online sales of hemp-derived products and intoxicating hemp drinks (LCB; CRC). A product sold legally where you bought it can be a controlled substance where you carry it, as in Texas, where delta-8 above natural trace amounts has been Schedule I since 31 Jul 2026 (DSHS). Licensed dispensary cannabis cannot cross state lines at all; California's regulator says so plainly, and our purchase-limits guide covers what you can carry inside each state.

TSA screening and national park rules are federal. TSA's page on medical marijuana marks it 'Yes (Special Instructions)' for both carry-on and checked bags; screeners are not looking for drugs, TSA says, but they pass any illegal substance they come across to a law enforcement officer (TSA, updated 27 Apr 2026). In national parks, possessing a controlled substance is prohibited except as 36 CFR 2.35(b)(2) allows, and a product outside the federal hemp definition is marijuana or a synthetic THC under federal law. Our flying guide and national parks guide set out the airport and park rules state by state.

DOT's testing rules do not accept hemp as an explanation. In a federally regulated transportation testing program, a medical review officer must not accept an employee's use of a hemp or other non-prescription marijuana-related product as a basis for verifying a marijuana test as negative (49 CFR 40.151(f)). The same section, last amended in 2023, bars verifying a test as negative because a physician recommended a drug listed in Schedule I, giving state medical marijuana laws as its example (49 CFR 40.151(e)); since 28 Apr 2026, marijuana held under a state medical license is in Schedule III.

Impaired-driving laws can name hemp too. Minnesota's DWI statute covers driving under the influence of cannabis flower, cannabis products, lower-potency hemp edibles, hemp-derived consumer products, artificially derived cannabinoids or tetrahydrocannabinols (Minn. Stat. 169A.20, subd. 1). Our driving guide sets out the rules in each of the 21 states.

Neither federal law sets a grace period for products already bought. The definition simply changes on 12 Nov 2026 for products with cannabinoids the plant cannot produce, and after 11 Dec 2026 for the rest (Pub. L. 119-37, s. 781, and Pub. L. 119-103, s. 2019). A product that stops being hemp on those dates becomes marijuana or a synthetic THC under federal law, whatever the date of purchase.

A few state regulators have addressed products already on hand. Connecticut's DCP says giving away delta-8 products is illegal, because the state's definition of a sale includes a transfer without payment (DCP, 3 Oct 2023). Texas's DSHS says a product labeled with delta-8 can be held by the agency and turned over to police (DSHS). New Jersey's CRC says hemp products above the April 2026 limits may be produced, sold or distributed only under a Commission license (CRC).

Missouri's new law speaks to sellers rather than buyers: from 12 Nov 2026, each sale of a covered product by an unlicensed seller counts as a class D felony and draws a fine of $5,000 (RSMo 195.900). Each state's rules page on this site names the regulator to ask about anything the law does not answer.